SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-068347
Filing Date
2023-06-06
Accepted
2023-06-06 08:08:38
Documents
3
Period of Report
2023-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317752-13_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317752-13_4seq1.xml 4 4721
2 EXHIBIT 24 tm2317752d13_ex24.htm EX-24 9373
3 GRAPHIC tm2317752d13_ex24img001.jpg GRAPHIC 3696
  Complete submission text file 0001104659-23-068347.txt   20880
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139
Business Address
Milne Jill C. (Reporting) CIK: 0001644246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 23994937